L½,&E¬' M78 E¬f
Transcript of L½,&E¬' M78 E¬f
![Page 1: L½,&E¬' M78 E¬f](https://reader030.fdocumento.com/reader030/viewer/2022012901/5ebeedb6e37b6b0fce734f47/html5/thumbnails/1.jpg)
–
–
–
–
•
2
–
–
•
•
–
![Page 2: L½,&E¬' M78 E¬f](https://reader030.fdocumento.com/reader030/viewer/2022012901/5ebeedb6e37b6b0fce734f47/html5/thumbnails/2.jpg)
–
–
–
–
–
Glycemic control
Date OHA regimen HbA1c plasma glucose (mg/dL)
2003/10/7 Metformin 10.2 AC: 138PC: 487
2004/2/27 Amaryl + Metformin one touch: >300
2005/11/23 Amaryl + Metformin AC: 137
2006/6/1 Metformin + Acarbose + Repaglinide 14.2
2006/10/31 Metformin + Acarbose + Gliclazide 7.9
![Page 3: L½,&E¬' M78 E¬f](https://reader030.fdocumento.com/reader030/viewer/2022012901/5ebeedb6e37b6b0fce734f47/html5/thumbnails/3.jpg)
![Page 4: L½,&E¬' M78 E¬f](https://reader030.fdocumento.com/reader030/viewer/2022012901/5ebeedb6e37b6b0fce734f47/html5/thumbnails/4.jpg)
![Page 5: L½,&E¬' M78 E¬f](https://reader030.fdocumento.com/reader030/viewer/2022012901/5ebeedb6e37b6b0fce734f47/html5/thumbnails/5.jpg)
![Page 6: L½,&E¬' M78 E¬f](https://reader030.fdocumento.com/reader030/viewer/2022012901/5ebeedb6e37b6b0fce734f47/html5/thumbnails/6.jpg)
![Page 7: L½,&E¬' M78 E¬f](https://reader030.fdocumento.com/reader030/viewer/2022012901/5ebeedb6e37b6b0fce734f47/html5/thumbnails/7.jpg)
––––
Kaplan-Meier plot of tuberculosis-free survival by diabetes mellitus and glycemic control status, adjusted for age
p-value from log-rank test for overall difference: 0.0019
14
poor glycemic control (FPG>130 mg/dL)
![Page 8: L½,&E¬' M78 E¬f](https://reader030.fdocumento.com/reader030/viewer/2022012901/5ebeedb6e37b6b0fce734f47/html5/thumbnails/8.jpg)
Results from Cox proportional hazards regression model for association between diabetes status, glycemic control, and risk of TB
15
Dose-response curves for fasting plasma glucose and risk of incident tuberculosis in the Cox proportional hazards model
16
p
![Page 9: L½,&E¬' M78 E¬f](https://reader030.fdocumento.com/reader030/viewer/2022012901/5ebeedb6e37b6b0fce734f47/html5/thumbnails/9.jpg)
Subgroup Analysis or Diabetes Status and Risk of TB
BMI and gender: not statistically significant effect modifiers
![Page 10: L½,&E¬' M78 E¬f](https://reader030.fdocumento.com/reader030/viewer/2022012901/5ebeedb6e37b6b0fce734f47/html5/thumbnails/10.jpg)
–
•
•
•
–
Baker et al, BMC Medicine 2011, 9:81
Lee et al, Plos one 2014
•
•
•
20
![Page 11: L½,&E¬' M78 E¬f](https://reader030.fdocumento.com/reader030/viewer/2022012901/5ebeedb6e37b6b0fce734f47/html5/thumbnails/11.jpg)
•
•
•
–•
•
21
••••
•
22
( ):
WHO: Collaborative framework for care and control of TB and DM
![Page 12: L½,&E¬' M78 E¬f](https://reader030.fdocumento.com/reader030/viewer/2022012901/5ebeedb6e37b6b0fce734f47/html5/thumbnails/12.jpg)
2018
–
––
––
––
![Page 13: L½,&E¬' M78 E¬f](https://reader030.fdocumento.com/reader030/viewer/2022012901/5ebeedb6e37b6b0fce734f47/html5/thumbnails/13.jpg)
•–
––
25
2018
![Page 14: L½,&E¬' M78 E¬f](https://reader030.fdocumento.com/reader030/viewer/2022012901/5ebeedb6e37b6b0fce734f47/html5/thumbnails/14.jpg)
••
••
•–
27
•
•
28
![Page 15: L½,&E¬' M78 E¬f](https://reader030.fdocumento.com/reader030/viewer/2022012901/5ebeedb6e37b6b0fce734f47/html5/thumbnails/15.jpg)
••
•––
–
29
•–
•
–
–•
30
![Page 16: L½,&E¬' M78 E¬f](https://reader030.fdocumento.com/reader030/viewer/2022012901/5ebeedb6e37b6b0fce734f47/html5/thumbnails/16.jpg)
31
2018
PDF: http://www.thearc.org.au/Resources/Uploaded/Resources/21812%20-%20ARC%20TB%20Diabetes%20Flipchart%20-%20WEB.pdf
![Page 17: L½,&E¬' M78 E¬f](https://reader030.fdocumento.com/reader030/viewer/2022012901/5ebeedb6e37b6b0fce734f47/html5/thumbnails/17.jpg)
DM-TB co-management: from evidence to action…
34
A1C : every 3 months
1% solution:
![Page 18: L½,&E¬' M78 E¬f](https://reader030.fdocumento.com/reader030/viewer/2022012901/5ebeedb6e37b6b0fce734f47/html5/thumbnails/18.jpg)
1 2 3 4 5 6
Intensive phase Continuation phase
HERZ HR(E)•
•
•
:
40
![Page 19: L½,&E¬' M78 E¬f](https://reader030.fdocumento.com/reader030/viewer/2022012901/5ebeedb6e37b6b0fce734f47/html5/thumbnails/19.jpg)
–
–
–
–
![Page 20: L½,&E¬' M78 E¬f](https://reader030.fdocumento.com/reader030/viewer/2022012901/5ebeedb6e37b6b0fce734f47/html5/thumbnails/20.jpg)
•
•
•
•
•
•
•
•
•
•
•
•
•
![Page 21: L½,&E¬' M78 E¬f](https://reader030.fdocumento.com/reader030/viewer/2022012901/5ebeedb6e37b6b0fce734f47/html5/thumbnails/21.jpg)
–
–
–
–
–
–
–
–
–